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Mononuclear silver(I) complexes with 1,7-phenanthroline (1,7-phen), [Ag(NO3-O,O0) (1,7-phen-N7)2] (1)
and [Ag(1,7-phen-N7)2]X, X¼ClO4 (2), CF3SO3 (3), BF4 (4) and SbF6 (5) were synthesized and struc-
turally characterized by NMR (1H and 13C), IR and UVeVis spectroscopy and ESI mass spectrometry. The
crystal structures of 1, 3 and 4 were determined by single-crystal X-ray diffraction analysis. In all these
complexes, 1,7-phen coordinates to the Ag(I) ion in a monodentate fashion via the less sterically hindered
N7 nitrogen atom. The investigation of the solution stability of 1e5 in DMSO revealed that they are
sufﬁciently stable in this solvent at room temperature. Complexes 1e5 showed selectivity towards
Candida spp. in comparison to bacteria, effectively inhibiting the growth of four different Candida species
with minimal inhibitory concentrations (MIC) between 1.2 and 11.3 mM. Based on the lowest MIC values
and the lowest cytotoxicity against healthy human ﬁbroblasts with selectivity index of more than 30, the
antifungal potential was examined in detail for the complex 1. It had the ability to attenuate C. albicans
virulence and to reduce epithelial cell damage in the cell infection model. Induction of reactive oxygen
species (ROS) response has been detected in C. albicans, with fungal DNA being one of the possible target
biomolecules. The toxicity proﬁle of 1 in the zebraﬁsh model (Danio rerio) revealed improved safety and
activity in comparison to that of clinically utilized silver(I) sulfadiazine.
1. Introduction
Candida albicans and emerging non-albicans Candida species,
such as C. parapsilosis, C. glabrata, C. tropicalis and C. krusei, may
cause infections ranging from superﬁcial to life-threatening
disseminated bloodstream and deep-tissue infections and ac-
count for 95% of all candidemia [1,2]. Existing therapies for the
treatment of Candida infections rely on the use of several classes of
compounds including polyenes, azoles, echinocandins, nucleoside
analogs and allylamines with varying efﬁcacy depending on the
type and site of the infection, as well as susceptibility of the Candida
species [3]. However, Candida species developed resistance to these
conventionally used antifungal agents, leading to the treatment
failures in patients and changes in the prevalence of species causing
diseases [4]. The mechanisms of resistance to the antifungal drugs
include an increased expression of drug efﬂux pumps which
remove the drug from the cell before a toxic concentration can be
reached, alteration of the structure or concentration of antifungal
target proteins, and variation in the ergosterol biosynthetic path-
ways [5,6]. The problems associated with the developing resistance
to the traditional therapy are a strong incentive for the search and
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development of alternative antifungal agents.
Metal complexes might represent a novel class of antifungal
agents due to their favorable features compared to the organic
compounds, such as enhanced stereochemistry and reactivity,
lipophilicity and redox potential [7] and possibly different modes
of antifungal action. Among all metals of which complexes were
found to be active against Candida species, silver has gained
considerable attention due to its high toxicity to microorganisms
and lower toxicity to mammalian cells [8]. The antimicrobial
properties of silver(I) ions have been known from the ancient time
and this metal ion represents an active agent in many healthcare
products such as silver-coated catheters, wound dressings and
burn-treatment creams [9e11]. An attractive class of ligands for
the synthesis of silver(I) complexes as potential antifungal agents
comprises aromatic nitrogen-containing heterocycles (N-hetero-
cycles) [8,12e22]. For instance, 1,10-phenanthroline (1,10-phen)
and its derivative, 1,10-phenanthroline-5,6-dione (1,10-phendio),
and the respective silver(I) complexes of the general formula
[Ag(L)2]ClO4 have been proven as very potent inhibitors of
C. albicans growth [14e19]. The mode of their action has been
examined and it was found that yeast cells after exposure to 1,10-
phen and its silver(I) complex had a lower ability to reduce 2,3,5-
triphenyltetrazolium chloride and, consequently, a reduced res-
piratory function [15,23]. Moreover, the [Ag(1,10-phen)2]ClO4
reduced the levels of cytochromes aa3, b and c, and led to a
decrease in cellular ergosterol amount. As a consequence of all
these processes, 1,10-phen and its silver(I) complex damaged
mitochondrial function and uncoupled respiration [15]. The effect
of these compounds on the structure of fungal and mammalian
cell organelles has been also investigated and the obtained results
showed that they were able to induce apoptosis in both types of
cells [16]. On the other hand, 1,10-phendio and [Ag(1,10-phendio)2]
ClO4 caused extensive and non-speciﬁc DNA cleavage, gross dis-
tortions in fungal cell morphology and disruption of cell division
[17,18].
The remarkable antifungal activity of silver(I) complexes with
aromatic N-heterocycles, particularly with 1,10-phenanthroline,
prompted us to synthesize and biologically evaluate silver(I)
complexes with 1,7-phenanthroline (1,7-phen) (Scheme 1). In
contrast to 1,10-phen, its structural isomer does not possess
chelating properties; nevertheless 1,7-phen could behave as
bridging ligand between two silver(I) ions by providing an acute
60 bridging angle [24]. However, due to the steric hindrance ef-
fect of the N1 nitrogen atom, 1,7-phen can also act as kN7 mon-
odentate ligand exclusively [24,25]. A previous study related to the
antifungal properties of 1,7-phen showed that, unlike 1,10-phen,
this compound and their copper(II), manganese(II) and zinc(II)
complexes displayed only marginal activity against C. albicans [14].
This was attributed to the fact that, although both 1,7- and 1,10-
phen can coordinate to the metal center, only 1,10-phen was
capable to chelate and form an extremely stable metal ion-phen
moiety in solution [14]. Despite these ﬁndings and as a continu-
ation of our efforts in the synthesis of biologically active silver(I)
complexes with aromatic N-heterocycles [26e28], in the present
study we have synthesized and structurally characterized ﬁve new
silver(I) complexes with 1,7-phen, [Ag(NO3-O,O0) (1,7-phen-N7)2]
(1) and [Ag(1,7-phen-N7)2]X, X¼ClO4 (2), CF3SO3 (3), BF4 (4) and
SbF6 (5) (Scheme 1). These complexes were assessed for in vitro
antimicrobial and antiproliferative activities against the normal
human lung ﬁbroblast cell line (MRC5) to properly address their
therapeutic potential. Considering the fact that complexes 1e5
have shown remarkable antifungal activity, the in depth antifungal
potential, including the toxicity in vivo on zebraﬁsh (Danio rerio)
was also examined.
2. Results and discussion
2.1. Synthesis and structural characterization of the silver(I)
complexes 1e5
The silver(I) complexes with 1,7-phenanthroline,
[Ag(NO3-O,O0) (1,7-phen-N7)2] (1) and [Ag(1,7-phen-N7)2]X,X¼ClO4
(2), CF3SO3 (3), BF4 (4) and SbF6 (5), were synthesized according to
the routepresented inScheme1. The reactionofAgNO3with1,7-phen
in a 2: 1mole ratio, respectively, in methanol/acetone (1: 1, v/v) at
room temperature yielded mononuclear complex 1. However, re-
actions of 1,7-phen with the other AgX salts (X¼ClO4, CF3SO3, BF4
and SbF6), resulting in formation of the complexes 2e5, were per-
formed in ethanol by mixing an equimolar amount of the reactants.
Despite the use of different silver(I) salts,1,7-phen reactedwith all to
form similar mononuclear species, in which this N-heterocyclic
ligand is monodentatedly coordinated to the Ag(I) ion through the
less sterically hindered N7 nitrogen atom. The characterization of
the complexes 1e5 was established on the basis of elemental anal-
ysis, NMR (1H and 13C), IR and UVeVis spectroscopy and ESI mass
spectrometry, while the crystal structures of 1, 3 and 4 were deter-
mined by single-crystal X-ray diffraction analysis. Simultaneous
attempts to crystallize complexes 2 and 5 from their amorphous
powders using different solvents (water, methanol, acetone, chlo-
roform, dimethylformamide) were unsuccessful.
2.1.1. Spectroscopic characterization
The NMR (1H and 13C), IR and UVeVis spectroscopic data for the
silver(I) complexes 1e5 are listed in the Experimental section (vide
infra), alongside with the corresponding data for 1,7-phen. The
proton NMR spectra for 1e5 measured in DMF-d7 were noticeably
different from that of the uncoordinated 1,7-phen. Monodentate
coordination of 1,7-phen to Ag(I) ion changes its electronic prop-
erties, resulting in appearance of eight proton signals in the spectra
of the complexes, instead of ﬁve in that of 1,7-phen. All proton
signals of 1e5 are shifted downﬁeld in respect to those of 1,7-phen.
Which one of the two nitrogen atoms (N1 or N7) of 1,7-phen is
coordinated to Ag(I) was deduced from the larger values of the
observed chemical shifts (determined in respect to the free ligand)
in the 1H NMR spectra of the complexes. Thus, D(1H)coord values
conﬁrm that 1,7-phen coordinates to Ag(I) ion via the less sterically
hindered nitrogen atom N7: D(1H)coord for H8 is larger than that for
its counterpart, H2. However, one could observe only small shifts of
the proton signals for complexes 1e5 with respect to those for 1,7-
phen, what seems to be spectroscopic feature of silver(I) complexes
in solution [29]. Although on the whole Ag(I) complexation of 1,7-
phen produced an overall deshielding of ring carbons in 1e5, the
signals of several carbon atoms were shifted upﬁeld. From the 13C
spectra of these complexes, one could also conclude that 1,7-phen
is coordinated to Ag(I) through the N7 nitrogen, considering the
largest shifts for the N7 adjacent carbons, C6 and C8, compared to
the free ligand. On the other hand, the signals of the other carbon
atoms are almost unaffected upon Ag(I) complexation.
The room temperature UVeVis spectra of silver(I) complexes
1e5, recorded in DMF/H2O, resemble that of the 1,7-phen. In all
complexes, the corresponding absorbance peak at ~269.0 nm,
respectively, can be attributed to p / p* transitions in phenan-
throline [25,30] and they show slight red shift compared to that for
the free ligand (l¼ 267.0 nm).
The IR spectra of the complexes measured in the wavenumber
range of 4000e450 cm1 show the bands attributable to the vi-
bration of the coordinated 1,7-phen, as well as those due to the
corresponding counter-anion in the complexes 2e5 [31e36]. This is
in accordance with the crystal structures of 3 and 4 determined by
X-ray diffraction analysis (vide infra). Complex 2 exhibits a very
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strong band with two sub-maxima at 1108 and 1064 cm1 and a
strong one at 622 cm1 which can be attributed to the n(ClO) and
d(OClO) modes, respectively, of the uncoordinated perchlorate [31].
The presence of the two bands attributed to the asymmetric
stretching vibration of ClO4 ion can be the consequence of its
participation in hydrogen bonding interactions, leading to its
“pseudomonodentate” spectroscopic behavior [31,32]. As far as
complex 5 is concerned, the presence of a strong band at 656 cm1
in its IR spectra, indicates no coordination of SbF6 to the Ag(I)
center [36]. On the other hand, a detailed analysis of the IR spectra
of 1 [37,38], indicates that NO3 is bidentatedly coordinated to the
Ag(I) ion in this complex.
ESI mass spectra. In the mass spectrometry of silver(I) com-
plexes, the presence of two isotopes of nearly equal abundance,
107Ag (51.84%) and 109Ag (48.16%), is quite useful, because their
mass spectra show doublet peaks with almost equal intensity for a
mononuclear species or triplet peaks with approximately 1: 2: 1 in-
tensity ratio, indicating the presence of dinuclear silver(I) species in
solution [13,39]. The positive ion ESI mass spectra for 1e5 show two
main doublet peaks centered at m/z¼ 468.0 and 361.0, consistent
with theoretical m/z values calculated for [Ag(1,7-phen)2]þ and
[Ag(1,7-phen) (DMF)]þ cations, respectively. This is in accordance
with the presence of mononuclear silver(I) species also in solution.
2.1.2. Description of the single crystal structures
The molecular structures of the silver(I) complexes 1 and 4
with the anisotropic displacement ellipsoids and the atom
numbering scheme are shown in Fig. 1, while their selected bond
distances (Å) and valence angles (o) are listed in Table S1. This table
also lists the corresponding structural parameters for complex 3,
which contains the same complex cation as 4, but a different
counter-anion (an ORTEP drawing of 3 is given in ESI, Fig. S1). As
can be seen in Fig. 1, complex 1 is a mononuclear species
comprising neutral [Ag(NO3-O,O0) (1,7-phen-N7)2] molecules. This
complex has a strongly distorted tetrahedral geometry about the
silver(I) ion, which is coordinated by two nitrogen atoms from two
1,7-phen ligands and by two oxygen atoms from the nitrate anion.
The distortion can be revealed from the t4 parameter [40] of 0.67,
t4¼ [360 e (b þ a)]/141 where b and a are the largest angles
around the metal ion (b¼N1dAgdN3¼154.78(15)o and
a¼N1dAgdO2¼110.83(15)o). Perfectly square-planar and tetra-
hedral geometries result in t4 values of 0 and 1, respectively [40].
The two nitrogen atoms of the 1,7-phen ligands are at almost
equidistance from the Ag(I) ion; the AgdN1/N3 distances adopt
values of 2.203(4) and 2.206(4) Å, respectively (Table S1) and
compare well with those found in the other pseudo tetrahedral
silver(I) complexes [27,41,42]. The AgdO(nitrate) bond distances in
1 are in the range of 2.630(4) e 2.652(4) Å, being much longer than
usual silver(I)-oxygen bonds of about 2.3Å [43]. This indicates that
the nitrate in 1 is only weakly bound to the silver(I) ion.
Similar to 1, silver(I) complexes 3 and 4 contain two mono-
dentatedly coordinated 1,7-phen ligands (Fig. 1 and Fig. S1). How-
ever, in contrast to 1, the corresponding anions, i.e. triﬂate in 3 and
tetraﬂuoroborate in 4, are not coordinating to the metal center.
Consequently, the Ag(I) ion adopts a slightly distorted linear ge-
ometry, with an N1dAg1dN3 angle of 174.2(3) and 166.6(3)o in 3
Scheme 1. Schematic presentation of the reactions for the synthesis of silver(I) complexes 1e5. Numbering scheme of carbon atoms in 1,7-phen is in agreement with IUPAC
recommendations for fused ring systems and does not match the one applied in the X-ray study of silver(I) complexes 1, 3 and 4. Considering the remarkable activity against all
tested Candida species and lower cytotoxicity, complex 1 was selected for further activity analysis.
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and 4, respectively (Table S1). As in 1, the nitrogen atoms of the two
1,7-phen ligands are at almost equidistance from the Ag(I) ion
(Table S1) and are comparable with the other N-heterocycle-sil-
ver(I) complexes [26,27,41,42].
2.2. Stability of complexes
The solution behavior of silver(I) complexes 1e5 was analyzed
by 1H NMR spectroscopy. For this purpose, these complexes were
dissolved in DMSO‑d6, and their 1H NMR spectra were recorded
directly after dissolution and after 48 h standing in the dark at room
temperature. For all complexes, 1H NMR spectra remained un-
modiﬁed over 48 h, implying their substantial stability in solution
during that time. More speciﬁcally, no decomposition of the com-
plexes to the free 1,7-phen and no coordination of DMSO to the
Ag(I) ionwere observed. As an illustration, the NMR spectra of 3 are
presented in Fig. S2 as a function of time.
In order to investigate the air/light stability of the silver(I)
complexes which might be of importance for their use as antimi-
crobial agents in the form of ointments, gels and coating materials
of dressings [29], sterile cellulose discs impregnated with these
complexes (5 mL of 50mg/mL DMSO stock solution) were exposed
to air and light for 48 h (Fig. S3). As can be seen from Fig. S3, all
investigated silver(I) complexes started to be a little beige in color
after 24 h, and after 48 h all were darker, indicating that slow light
decomposition processes occurred during this time.
2.3. Biological activity of the silver(I) complexes
2.3.1. Antimicrobial activity
Silver(I) complexes 1e5 and the corresponding 1,7-phen ligand
were evaluated for their activity against ﬁve bacterial strains,
including Gram-negative Escherichia coli, Pseudomonas aeruginosa,
Klebsiella pneumoniae, and Gram-positive Staphylococcus aureus
and Enterococcus faecalis as well as four Candida spp. (C. albicans,
C. parapsilosis, C. glabrata and C. krusei). Their antibacterial activity
was compared with the antibacterial properties of silver(I) sulfa-
diazine (AgSD), a topical antibiotic used in partial thickness and full
thickness burns to prevent infection for more than 40 years [44,45].
MIC values against bacterial strains for silver(I) complexes 1e5
were between 25 and 125 mM (Table 1). The investigated silver(I)
complexes showed considerably higher antibacterial potency
compared to the starting 1,7-phen ligand, however, their MIC
values in comparison to that of AgSD were either comparable or
higher, indicating moderate antibacterial activity (Table 1). These
MIC values are comparable with that of silver(I) complexes of 2,20-
bipyridine and 1,10-phenanthroline [22]. On the other side, 1e5
showed considerable antifungal activity against all tested Candida
strains, with C. krusei and C. albicans being the most sensitive.
Antifungal activity was comparable or better to that of AgSD, with
MIC concentrations between 1.2 and 11.3 mM (Table 1). Especially, in
the case of complex 1 that showed 5-fold lower MIC value against
C. albicans and 4-fold lower cytotoxicity, in comparison to AgSD
(Table 1). Generally,1e5were moderately cytotoxic against healthy
human ﬁbroblasts, with selectivity index in respect to anti-Candida
activity for 1 being 30 in the case of C. parapsilosis (Table 1). Such
remarkable anti-Candida activity has been observed for [Ag2(1,10-
phen)3(mal)].2H2O, [Ag(1,10-phen)2]ClO4 and [Ag(1,10-phendio)2]
ClO4 complexes, whereby starting 1,10-phenanthroline and 1,10-
phenanthroline-5,6-dione ligands also exerted strong antifungal
activity [14e19]. On the contrary, 1,7-phen had only marginal
antifungal effect (Table 1). Moreover, the most anti-Candida active
[Ag(1,10-phendio)2]ClO4 complex was toxic to the non-neoplastic
cell lines, suggesting its inability to selectively kill fungal cells,
while leaving the normal cells viable [19].
In contrast to the complexes 1e5, the previously synthesized
silver(I) complexes with aromatic N-heterocycles having two ni-
trogens within one ring, such as diazines (pyridazine, pyrimidine,
pyrazine), benzodiazines (phthalazine, quinazoline, quinoxaline)
and tricyclic phenazine, showed considerable antibacterial activity,
while their efﬁcacy in inhibiting C. albicans growth was moderate
[26e28]. These complexes were particularly efﬁcient against
pathogenic P. aeruginosa, and had a marked ability to disrupt clin-
ically relevant bioﬁlms of strains with high inherent resistance to
antibiotics [27,28]. However, they were more cytotoxic against
healthy human ﬁbroblasts than most of the presently reported
Fig. 1. Molecular structures of the silver(I) complexes 1 and 4. Non-coordinating tetraﬂuoroborate anion in 4 is omitted for clarity. Displacement ellipsoids are drawn at 50%
probability level and H atoms are represented by spheres of arbitrary size.
Table 1
Antimicrobial activity of silver(I) complexes 1e5, 1,7-phen and silver(I) sulfadiazine
(AgSD), in comparison to their antiproliferative effect on healthy human ﬁbroblast
MRC5 cell line.
Minimal inhibitory concentrations (MICs, mM)
Test organism 1 2 3 4 5 1,7-phen AgSD
E. coli 75a 80 80 100 70 500 50
P. aeruginosa 50 25 80 25 40 500 25
K. pneumoniae 100 88 80 100 80 500 75
S. aureus 125 100 80 90 125 500 75
E. faecalis 80 44 42 45 40 500 100
C. albicans 1.8 5.5 10.1 5.6 4.4 500 10
C. parapsilosis 1.2 11.0 10.1 11.3 8.9 500 2.5
C. glabrata 10 11 10.1 11.3 8.9 600 5.1
C. krusei 2.5 5.5 5.1 5.6 8.5 500 2.5
MRC5 cells 40b 15 25 12.5 20 135 10
aResults are given as mean of three independent measurements with standard error
being between 1 and 3%.
bCalculated IC50 values correspond to concentrations required to inhibit 50% of cell
growth.
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complexes [26e28].
Considering the improved therapeutic window and the
remarkable activity against all tested Candida species coupled with
the fact that structural differences to other complexes were in the
different counter ion, 1 was selected for further activity analysis.
2.3.2. Anti-Candida activity of 1
2.3.2.1. Effect on C. albicans SC5314 virulence in epithelial infection
model. In vitro epithelial cell models are well established to study
different stages of infection, from adhesion to the host cells, via
hyphal formation ﬁnally damage of the hosts cells by contact-
sensing, directed hyphal extension, active penetration and secre-
tion of the newly discovered toxin candidalysin [46,47]. For 1 and
silver(I) sulfadiazine (AgSD), MIC± one dilution was tested in oral
epithelial cell model with human TR-146 cells where invasion
(hyphal length) and the damage of the host cells were assessed
(LDH release; LDH is lactate dehydrogenase) (Fig. 2). So far, cop-
per(II) and zinc(II) complexes with 2,20-bipyridine were reported to
interact and inhibit LDH protein [48].
The presence of the MIC concentrations of 1 and AgSD reduced
the hyphal length similarly by 10e15% in comparison to untreated
control (Fig. 2A and B). At the concentrations one dilution higher
than MIC, both complexes had similar efﬁciency in reducing the
damage (24e30% reduction, Fig. 2C). However, in MIC and sub-MIC
concentrations, the presence of 1 leads to the higher reduction of
epithelial damage comparing to AgSD (Fig. 2C). A relatively mod-
erate reduction of damage, in general, could be explained by the
fact that the epithelial damage is measured 24 h post-infection and
it could be that C. albicans develops certain adaptations and initi-
ates other pathogenicity mechanisms which still leads to the
damage despite the presence of the compounds.
2.3.2.2. Reactive oxygen species (ROS) generation in C. albicans.
The fungicidal activity of antifungal compounds is often attributed
to the ROS production [49]. Generation of ROS in C. albicans treated
with 2-fold MIC concentrations of silver(I) complex 1, 1,7-phen,
AgSD and amphotericin B (AmB) was quantiﬁed using 20,70-
dichloroﬂuorescin diacetate (DCFH-DA) staining and indicated by
20,70-dichloroﬂuorescein (DCF) ﬂuorescence due to DCFH-DA probe
oxidation (Fig. 3). Quantiﬁcation of cellular ROS generation by ﬂow
cytometry revealed more pronounced increase in DCF ﬂuorescence
after 1.5 h of incubation with silver(I) complex 1 compared to AmB,
clinically used antifungal, known for its ability to induce apoptosis
and hence ROS production in C. albicans [49] (Fig. 3). Generation of
ROS in C. albicans treated with 1,7-phenwas almost the same as the
control sample, cells treatedwith DMSO. Notably, the effect of AgSD
on the ROS generation in C. albicans was 30-fold higher in com-
parison to both 1 and AmB. This may not be surprising, as AgSD has
been connected with numerous side effects and toxicity [50]. Taken
together, these results suggest that eradication of Candida induced
by silver(I) complex 1 could be due to ROS production upon pro-
longed exposure, being in accordance with the previously pub-
lished ﬁndings for the mechanism of action of silver(I)-containing
species [51].
2.3.3. In vitro DNA binding and molecular docking
We have examined the possibility that ROS generation observed
in C. albicans treated with 1 (Fig. 3) may be due to the initial
interactionwith fungal DNA. The prediction of drug binding to DNA
at molecular level, provided by molecular docking, is the basis of
Fig. 2. The effect of 1 and AgSD on C. albicans SC5314 virulence in epithelial infection model. (A) Invasion (100  magniﬁcation), (B) hyphal length and (C) % cell damage in
comparison to DMSO treated cells (*P < 0.5, Student t-test).
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new drug compounds design strategies. Inmost cases, drug binding
is non-covalent, although in the case of reactive drugs covalent
bonds may be formed [52,53]. Four different modes of drug binding
to DNA are known: intercalation of drug between adjacent base
pairs, drug binding into the minor groove, binding into the major
groove, and backbone tracking binding. For small molecules, the
main binding modes are intercalation and minor groove binding
[52e54]. Sequence speciﬁcity for these binding modes is signiﬁ-
cantly higher for binding into the minor groove binders than for
intercalators [52,54]. The majority of intercalating drugs show
preferences to GC-rich sequences and regionwith alternating G and
C bases [54,55]. The intercalation requires conformational changes
of the DNA owing to formation of a binding cavity [52,53], which is
not required for the minor groove binding. Majority of drugs
bonded into the minor groove have a preference of binding to AT-
rich sequences [53,56,57]. The major groove offers greater oppor-
tunity for forming hydrogen bonds with the drug [52], although the
proteins often occupy this groove. The minor groove binding drugs
can effect on biological activity of these proteins [54].
Although nucleic acids are more ﬂexible than proteins [58e61],
the treatment of DNA as a rigid molecule during docking study does
not necessarily lead to worthless results if the sequence DNA base
and structure of drug take it into consideration. Namely, the
binding of 1,7-phen in AT-rich region of DNAminor groove (Fig. 4A)
indicates that the intercalation probably is not an appropriate
binding mode to DNA. Also, in accordance with the tendency of
complex 1 to bind into the minor groove in the AT-rich region
(Fig. 4A), it may be expected that the intercalation of this complex is
not an appropriate binding mode to DNA. However, by visual
analysis of crystal structures from Protein Data Bank, we found that
metal complexes with aromatic ligands intercalate between adja-
cent base pairs. On the other hand, Monte Carlo simulations
showed that there is a possible migration from AT-rich region into
the minor groove to site between adjacent base pairs, and achieved
that van der Waals interactions are the driving force for this
migration [62]. In accordance with the results of visual analysis and
MC simulations, we can presume that the intercalation probably is
an appropriate binding mode to DNA for complex 1. Despite
stronger binding of complex 1 into the minor groove of DNA
(7.06 kcal/mol) than 1,7-phen (3.83 kcal/mol), the nature of its
interactions with DNA is in favor of the previous presumption.
Namely, both examined compounds form only weak non-covalent
interactions with a DNA (weak hydrogen bonds, van der Waals
interaction and interactions of p-system). Complex 1 has only two
rotatable bonds (AgdN coordination bonds) as internal degrees of
freedom, that allow the conformation of the complex in which the
one 1,7-phen ligand is intercalated between the base pairs, and the
other one is bonded into the minor groove in the AT-rich region.
The intercalation of the second 1,7-phen ligand is conformationally
restricted, because of the coordination (NdAgdN) angle strain.
In vitro DNA interaction evaluation by gel electrophoresis, revealed
that under the tested conditions neither 1 nor 1,7-phen were able
to interact with C. albicans double stranded genomic DNA in a way
to prevent ethidium bromide binding and they were not causing
DNA degradation (Fig. 4B). This is in contrast to 1,10-phendio and
[Ag(1,10-phendio)2]ClO4 that caused extensive and non-speciﬁc
DNA cleavage [17,18]. Furthermore, circular dichroism (CD) spec-
troscopy has also been used as a useful technique for analyzing
interactions between the metal complexes and DNA, and it is also
very sensitive to the mode of DNA interactionwith small molecules
[63]. The CD spectrum of double-stranded template DNA (dsDNA)
isolated from herring sperm exhibits a positive band at 277 nm due
to base stacking interactions and a negative band at 245 nm due to
helicity and is characteristic of DNA in right-handed B form [64]. It
is well known that intercalation tends to enhance the intensities of
both bands due to strong base stacking interactions and stable DNA
conformations. On the other side, simple groove binding and
electrostatic interactions with small molecules show less or no
perturbation on the base-stacking and helicity bands. In the pres-
ence of the complex 1 at relatively high concentration of 400 mM, an
increase in intensity of the positive band and decrease in intensity
of the negative band of DNA have been observed (Fig. 4C). In
Fig. 3. Reactive oxygen species (ROS) generation in C. albicans cells treated with 2-fold MIC concentrations of silver(I) complex 1, 1,7-phenanthroline (1,7-phen), AgSD and AmB
(amphotericin B) for 1.5 h. ROS were detected using 20 ,70-dichloroﬂuorescin diacetate (DCFH-DA) staining with cells treated with DMSO used as a control.
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addition, this complex showed a red-shift in the positive and
negative bands, suggesting conformational change of a B-form DNA
to A-form DNA caused by interaction between DNA molecule and
the complex. Similar result was observed for [Ag(2,9-dimethyl-
1,10-phenanthroline)2]NO3∙H2O complex bound to DNA [65].
Most of ‘DNA drugs’ are generally positively charged aromatic
compounds [52]. Thus, [Ag(1,10-phen)2]NO3 complex has both
properties and binds into the minor groove in the GC-rich region
(Fig. S4). This complex has a lower binding energy (4.80 kcal/mol)
than complex 1 (7.06 kcal/mol), and weak non-covalent in-
teractions between complex and DNA are responsible for its bind-
ing into the minor groove. However, it is known that the [Ag(1,10-
phen)2]NO3 complex interacts with DNA by intercalating one of the
phenanthroline ligands into a DNA helix [66]. Although the com-
plex 1 has a slightly higher afﬁnity for binding to the DNA, these
two complexes bind to different regions, therefore, their binding
into the minor groove is unimpeded.
Overall, DNA may not be the primary target of 1 within Candida
cells, however it may be one of the biomolecules that this silver(I)
complex interacts with.
2.4. Toxicity and therapeutic safety assessment of 1 in zebraﬁsh
embryos
Zebraﬁsh has been suggested as suitable animal model for
in vivo drug discovery and development [67], and has been suc-
cessfully utilized for the safety assessment of metal complexes with
biomedical application [25,28]. Therefore, the toxicity of the com-
plex 1 was investigated using the 6 hpf zebraﬁsh (Danio rerio)
embryos in a 114 h exposure study and compared with the toxicity
of the 1,7-phen and AgSD as a clinically used antimicrobial agent.
The results obtained in this study showed that both 1 and 1,7-phen
were less toxic (lethal and teratogenic) than AgSD (Fig. 5A). These
results of the toxicity in vivo are in agreement with the results
obtained on the human ﬁbroblast (MRC5) cells (Table 1).
Based on the determined LC50 values, 1 was slightly (1.2-fold)
less toxic to zebraﬁsh embryos than AgSD and 7.8-fold more toxic
than 1,7-phen. All embryos exposed to 10 mM of 1 showed possible
small pericardial edemas and a few of them had slightly reduced
head (Fig. 5B). Complex 1 elicited no toxic response (lethal nor
teratogenic) in zebraﬁsh embryos upon treatment with doses close
to anti-C. albicans and C. parapsilosisMIC values (Table 1), indicating
favorable therapeutic proﬁle of this complex. The LC50 values of 1,7-
phen are in line with our recently published results [25].
With the aim to compare the therapeutic potential of 1 to that of
AgSD, we determined their therapeutic index (Ti) and the thera-
peutic safety index (Ts) (Table 2). AgSD appeared more toxic
(teratogenic) than 1 and exerted side effects at the doses bellow its
anti-Candida MIC values, such as developmental abnormalities
already at 1 mM and the cardiotoxicity at 2.5 mM demonstrating
low therapeutic safety (Table 2). To the best of our knowledge this is
the ﬁrst study exploring a dose-dependent toxicity of AgSD in the
zebraﬁsh model.
It is also important to note that 1 did not affect cardiovascular
functions of zebraﬁsh embryos in constrast to AgSD (Fig. S5).
Numerous studies highlighted cardiac toxicity (cardiomyopathy,
arrhythmias, cardiac enlargement and failure) in patients receiving
some antifungal drugs, such as azoles (ketonazole, itraconazole and
ﬂuconazole), echinocandins, and especially amphotericin B and its
derivatives [68e70]. Therefore, development of novel antifungals
without inherent cardiotoxic implications is critical.
Based on therapeutic index, it can be concluded that complex 1
present novel antifungal compound with much higher therapeutic
potential and safety proﬁle than silver(I) sulfadiazine, what
together with a spectrum of its antifungal activities makes this
complex as an excellent candidate for further application to combat
Fig. 4. In vitro interaction of silver(I) complex 1 with DNA. (A) The structures of DNA (pdb code-1BNA), complex 1 and 1,7-phen and the most stable binding of the investigated
compounds to DNA, as assessed by molecular docking. (B) In vitro interaction with C. albicans chromosomal DNA assessed by gel electrophoresis (100 ng/mL DNA treated with 25 mM
compounds for 2 h in 10mM Tris-Cl, pH 8.5) and (C) CD spectra of DNA (1mg/mL) treated with complex 1 (400 mM).
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candidal infections.
2.4.1. Oxidative stress in zebraﬁsh embryos upon exposure to 1
It is well known that the long-term application of some com-
mercial antifungals, like amphotericin B, is limited due to the
toxicity towards human kidney cells associated with generation of
oxidative stress [71,72], as well as towards normal human dermal
ﬁbroblasts [73]. Therefore, an evaluation of novel antifungal agents
for the potential to provoke oxidative stress in vivo and inﬂict the
oxidative stress-mediated damages is of great importance for their
further medical application.
Assessment of ROS production performed in this study using the
zebraﬁsh model revealed signiﬁcant differences in the oxidative
stress response between embryos exposed to 1 and AgSD (Fig. 6).
These differences became visible already at the doses correspond-
ing to the MIC values, at which 1 generated markedly less ROS than
AgSD (P< 0.05, Student t-test; Fig. 6A). Moreover, the ROS level
measured in embryos upon the MIC doses of 1 did not differ
signiﬁcantly from the basal level detected in the control group
(P 0.05; Student t-test), while AgSD treatment signiﬁcantly
increased embryos' ROS at the MIC dose, accounting for 127%
compared to the control group (P 0.05, Student t-test; Fig. 6B).
It is noteworthy that complex 1, exhibiting the best antifungal
activity (Table 1) and therapeutic potential (Table 2), did not elevate
the ROS production in zebraﬁsh embryos even at the 5MIC dose
(data not shown) neither caused developmental abnormalities,
demonstrating thus a very good overall toxicity proﬁle. Only at a
dose of the 6MIC value,1weakly increased the oxidative stress in
exposed embryos (up to 111± 4%; Fig. 6B), mostly manifested as a
visible ﬂuorescence of pericardial sac (Fig. 6A), while not disturbing
normal heartbeat rate. On the other side, AgSD-treated embryos
displayed intensive ﬂuorescence over the whole body and car-
diotoxic side effects (pericardial sac ﬂuorescence accompanied
with pericardial edema) already upon a dose corresponding to the
MIC value, additionally conﬁrming their low therapeutic safety
in vivo. Such side effects were particularly pronounced at a 4MIC
dose (Fig. 6B). Previous studies performed in the zebraﬁsh model
evidenced oxidative stress as one of themechanisms of silver-based
compounds' toxicity, whereas cardiotoxicity has been frequently
reported as the toxic effect caused by Agþ ions [74,75]. Absence of
cardiotoxicity and detectable oxidative stress in the zebraﬁsh
model during the treatments with 1 at antifungal doses (MIC)
demonstrates better pharmacological properties of this
phenanthroline-based silver(I) complex in comparison to the clin-
ically used antifungals.
3. Conclusion
In the present research study, ﬁve novel silver(I) complexes with
1,7-phenanthroline as ligand (1e5) were synthesized, structurally
characterized and biologically evaluated. The spectroscopic and
crystallographic results revealed that all synthesized silver(I)
complexes are mononuclear species with the metal ion being
monodentatedly coordinated by two ligand molecules via less
sterically hindered N7 nitrogen. These complexes showed selec-
tivity towards Candida spp. in comparison to bacteria, being
moderately cytotoxic against healthy human ﬁbroblasts. Complex 1,
which showed the best therapeutic potential, attenuated C. albicans
virulence and reduced epithelial cell damage in the cell infection
model. Moreover, this complex induced the ROS response in
C. albicans, with fungal DNA being one of the possible target bio-
molecules. Besides that, in vivo assessment performed on the
zebraﬁsh embryos showed that this complex was less toxic than
silver(I) sulfadiazine, which is the clinically used antimicrobial,
without affecting cardiovascular functions and elevating the ROS
production in the zebraﬁsh embryos. Taken all these together, sil-
ver(I) complex 1 may present novel potent antifungal compound
with favorable pharmacological properties, being more effective
and safe than the clinically used silver(I) sulfadiazine.
4. Experimental section
4.1. Materials
Distilled water was demineralized and puriﬁed to a resistance of
Fig. 5. Toxicity assessment of silver(I) complex 1, 1,7-phen and silver(I) sulfadiazine
(AgSD) in zebraﬁsh embryos exposed to different concentrations (1e50 mM) (A).
Morphology of zebraﬁsh embryos at 114 hpf upon different treatments (B). Embryos
exposed to 10 mM of 1 (slightly affected), and AgSD (severely malformed) are shown.
Malformed head (bracket), reduced eyes (asterisk) and otoliths (boxed) size, large
pericardial edema (arrow).
Table 2
Evaluation of the therapeutic index (Ti) and the therapeutic safety index (Ts) of 1 in
comparison to silver(I) sulfadiazine (AgSD).
Compound MIC (mM) LC50 (mM) EC50 (mM) Ti Ts
1 1.8 5.89 4.13 3.27 2.29
AgSD 10 5.02 2.23 0.50 0.22
MIC e the minimal inhibitory concentration determined against C. albicans.
LC50 e the concentration causing lethal effect at 50% zebraﬁsh embryos.
EC50 e the concentration inducing side effects (lethality and teratogenicity) at 50%
embryos.
Ti e the therapeutic index determined as the ratio between LC50 value and MIC
value.
Ts e the therapeutic safety index determined as the ratio between EC50 value and
MIC value.
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greater than 10MU cm. The starting silver(I) salts (AgNO3, AgClO4,
AgCF3SO3, AgBF4 and AgSbF6), 1,7-phenanthroline (1,7-phen),
methanol, ethanol, acetone, acetonitrile, dimethyl sulfoxide
(DMSO), dimethylformamide (DMF), deuterated dimethylforma-
mide (DMF-d7) and dimethyl sulfoxide (DMSO‑d6) were purchased
from Sigma-Aldrich. All the employed chemicals were of analytical
reagent grade and used without further puriﬁcation.
4.2. Measurements
Elemental microanalyses of the synthesized silver(I) complexes
for carbon, hydrogen and nitrogen were performed by the Micro-
analytical Laboratory, Faculty of Chemistry, University of Belgrade
and Adolphe Merkle Institute, University of Fribourg. All NMR
spectra were recorded at 25 C on a Bruker Avance III 400MHz
spectrometer (1H at 400MHz, 13C at 101MHz). 5mg of each com-
pound was dissolved in 0.6mL of DMF-d7 and transferred into a
5mm NMR tube. Chemical shifts are reported in ppm (d) and scalar
couplings are reported in Hertz. In order to investigate the solution
behavior of silver(I) complexes, the 1H NMR spectra were recorded
immediately after their dissolution in DMSO‑d6 (DMSO is a solvent
used for biological evaluation of the complexes), as well as after
48 h standing in the dark at room temperature. The IR spectra were
recorded as KBr pellets on a Perkin Elmer Spectrum 100 spec-
trometer over the wavenumber range of 4000e450 cm1. The ESI-
MS spectra in positive mode were recorded after dissolving the
silver(I) complexes 1e5 in DMF/H2O (1: 9, v/v) mixture with a
Bruker Esquire Ion Trap mass spectrometer. The UVeVis spectra
were recorded over the wavelength range of 900e200 nm on a
Shimadzu double-beam spectrophotometer after dissolving the
silver(I) complexes 1e5 in DMF/H2O (1: 9, v/v). The concentration
of the silver(I) complexes was 1.3.105M.
4.3. Synthesis of silver(I) complexes
4.3.1. Synthesis of 1
Silver(I) complex [Ag(NO3-O,O0) (1,7-phen-N7)2] (1) was syn-
thesized according to themodiﬁed procedure for the preparation of
silver(I) complexes with phthalazine and quinazoline [26]. The
solution of 1.0mmol of AgNO3 (169.9mg of AgNO3) in 15 mL of
warm methanol was added slowly under stirring to the solution
containing 0.5 mmol (90.1 mg) of 1,7-phen, dissolved in 15 mL of
warm acetone. The reactionmixturewas stirred in the dark at room
temperature for 3 h. A white precipitate, which was formed after
evaporation of the mother solution at room temperature, was
ﬁltered off and dissolved in acetonitrile. The obtained solution was
left to slowly evaporate at room temperature to a volume of 5.0 mL,
and then stored in a refrigerator at þ4 C. After two days colorless
crystals of 1, suitable for single crystal X-ray crystallography were
formed. Yield (calculated on the basis of N-heterocyclic ligand):
100.8mg (76%).
Anal. calcd. for 1¼ C24H16AgN5O3 (MW¼ 530.29): C, 54.36; H,
3.04; N, 13.21. Found: C, 53.95; H, 2.92; N, 13.37%. 1H NMR
(400MHz, DMF-d7): d¼ 8.02 (dd, J¼ 8.1, 4.4 Hz, H4), 8.13 (dd,
J¼ 8.3, 4.6 Hz, H10), 8.42 (d, J¼ 9.1 Hz, H3), 8.46 (d, J¼ 9.1 Hz, H9),
8.79 (dd, J¼ 8.1, 1.7 Hz, H5), 9.34 (dd, J¼ 4.4, 1.7 Hz, H2), 9.42 (dd,
J¼ 4.5, 1.7 Hz, H8), 9.88 ppm (dd, J¼ 8.3, 1.7 Hz, H6). 13C NMR
(101MHz, DMF-d7): d¼ 122.85 (C10), 123.47 (C4), 126.54 (C4a),
127.32 (C10a), 128.89 (C3), 130.33 (C9), 133.31 (C6), 136.68 (C5),
145.53 (C1a), 149.16 (C6a), 150.48 (C2), 152.72 ppm (C8). IR (KBr, n,
Fig. 6. Reactive oxygen species (ROS) production in zebraﬁsh embryos exposed to different doses (1MIC, 4MIC and 6MIC) of 1 and AgSD. A) ROS levels were determined by
measuring the ﬂuorescence of individual zebraﬁsh embryos. B) Statistically signiﬁcant differences between data of untreated control and treatments were denoted with asterisk
(*P < 0.5, **P < 0.01; ***P < 0.001; Student t’ test).
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cm1): ~3040w, 2921w (n(CareH)), 1617w, 1599m, 1573w, 1496m
(n(Car¼ Car) and n(Car¼N)), 1384vs and 1297s (nas(NO3)), 836s,
773s (g(CareH)), 726w and 700w (d(NO3)). UVeVis (DMF/H2O, lmax,
nm): 268.0 (ε¼ 4.1.104M1cm1). (þ)ESI-MS (DMF/H2O) m/z
(relative intensity): 468.0 [Ag(1,7-phen)2]þ (100), 361.0 [Ag(1,7-
phen) (DMF)]þ (10).
4.3.2. Synthesis of 2e5
Silver(I) complexes [Ag(1,7-phen-N7)2]X, X¼ClO4 (2), CF3SO3
(3), BF4 (4) and SbF6 (5) were synthesized according to the modi-
ﬁed procedure for the preparation of silver(I) complexes with
phthalazine, quinazoline and 2,3-diphenylquinoxaline [27,76]. The
solution of 1.0mmol of the corresponding silver(I) salt (207.3mg of
AgClO4 for 2, 256.9mg of AgCF3SO3 for 3, 194.7mg of AgBF4 for 4
and 343.6mg of AgSbF6 for 5) in 5.0mL of ethanol was added
slowly under stirring to the solution containing an equimolar
amount of 1,7-phen (180.2mg) in 20.0mL of warm ethanol. The
reaction mixture was stirred in the dark at room temperature for
3 h. The solid products of complexes 2 and 5 precipitated during
this time or after evaporation of the mother solution at room
temperature, respectively, were ﬁltered off and dried in the dark at
ambient temperature. Our attempts to obtain the crystals suitable
for X-ray analysis for these complexes from their amorphous
powders using different solvents were unsuccessful. However,
complexes 3 and 4 were crystallized from mother ethanol solution
after its standing at room temperature for several days. Yield
(calculated on the basis of the N-heterocyclic ligand): 193.0mg
(68%) for 2, 222.2mg (72%) for 3, 177.6mg (64%) for 4 and 183.4mg
(52%) for 5.
Anal. calcd. for 2¼ C24H16AgClN4O4 (MW¼ 567.73): C, 50.77; H,
2.84; N, 9.87. Found: C, 51.17; H, 2.70; N, 9.31%. 1H NMR (400MHz,
DMF-d7): d¼ 8.01 (dd, J¼ 8.1, 4.4 Hz, H4), 8.10 (dd, J¼ 8.3, 4.5 Hz,
H10), 8.40 (d, J¼ 9.1 Hz, H3), 8.47 (d, J¼ 9.1 Hz, H9), 8.78 (dd, J¼ 8.1,
1.7 Hz, H5), 9.33 (dd, J¼ 4.4, 1.7 Hz, H2), 9.39 (dd, J¼ 4.5, 1.7 Hz, H8),
9.85 ppm (ddd, J¼ 8.3, 1.7, 0.7 Hz, H6). 13C NMR (101MHz, DMF-d7):
d¼ 122.85 (C10), 123.47 (C4), 126.54 (C4a), 127.31 (C10a), 128.89
(C3), 130.31 (C9), 133.29 (C6), 136.68 (C5), 145.49 (C1a), 149.20
(C6a), 150.48 (C2), 152.69 ppm (C8). IR (KBr, n, cm1): ~3048w,
2923w (n(CareH)), 1617w, 1600m, 1575w, 1497m (n(Car¼ Car) and
n(Car¼N)), 1108vs and 1064s (n(ClO4)), 833s, 775s (g(CareH)), 622s
(d(OClO)). UVeVis (DMF/H2O, lmax, nm): 269.0
(ε¼ 5.1.104M1cm1). (þ)ESI-MS (DMF/H2O) m/z (relative in-
tensity): 468.0 [Ag(1,7-phen)2]þ (100), 361.0 [Ag(1,7-phen)
(DMF)]þ (3).
Anal. calcd. for 3¼ C25H16AgF3N4O3S (MW¼ 617.35): C, 48.64;
H, 2.61; N, 9.08. Found: C, 48.92; H, 2.54; N, 8.89%. 1H NMR
(400MHz, DMF-d7): d¼ 8.02 (dd, J¼ 8.3, 4.5 Hz, H4), 8.11 (dd,
J¼ 8.3, 4.5 Hz, H10), 8.41 (d, J¼ 9.1 Hz, H3), 8.48 (d, J¼ 9.1 Hz, H9),
8.79 (dd, J¼ 8.1, 1.7 Hz, H5), 9.34 (dd, J¼ 4.4, 1.7 Hz, H2), 9.40 (dd,
J¼ 4.5, 1.8 Hz, H8), 9.86 ppm (ddd, J¼ 8.3, 1.7, 0.7 Hz, H6). 13C NMR
(101MHz, DMF-d7): d¼ 122.88 (C10), 123.50 (C4), 126.55 (C4a),
127.35 (C10a), 128.88 (C3), 130.38 (C9), 133.39 (C6), 136.69 (C5),
145.53 (C1a), 149.15 (C6a), 150.51 (C2), 152.79 ppm (C8). IR (KBr, n,
cm1): ~3047w, 2923w (n(CareH)), 1616w, 1602m, 1575w, 1499m
(n(Car¼ Car) and n(Car¼N)), 1286vs (nas(SO3)), 1247vs (ns(CF3)),
1155s (nas(CF3)), 1027s (ns(SO3)), 835s, 771s (g(CareH)), 754m
(ds(CF3)), 637m (ds(SO3)), 594m (das(CF3)), 516m (das(SO3)). UVeVis
(DMF/H2O, lmax, nm): 269.0 (ε¼ 4.1.104M1cm1). (þ)ESI-MS
(DMF/H2O) m/z (relative intensity): 468.0 [Ag(1,7-phen)2]þ (100),
361.0 [Ag(1,7-phen) (DMF)]þ (17).
Anal. calcd. for 4¼ C24H16AgBF4N4 (MW¼ 555.09): C, 51.93; H,
2.91; N, 10.09. Found: C, 51.87; H, 2.79; N, 10.10%. 1H NMR
(400MHz, DMF-d7): d¼ 8.01 (dd, J¼ 8.0, 4.3 Hz, H4), 8.09 (dd,
J¼ 8.2, 4.5 Hz, H10), 8.38 (d, J¼ 9.0 Hz, H3), 8.46 (d, J¼ 9.1 Hz, H9),
8.78 (d, J¼ 8.1 Hz, H5), 9.33 (d, J¼ 4.3 Hz, H2), 9.37 (d, J¼ 4.3 Hz,
H8), 9.84 ppm (d, J¼ 8.3 Hz, H6). 13C NMR (101MHz, DMF-d7):
d¼ 122.79 (C10), 123.42 (C4), 126.53 (C4a), 127.20 (C10a), 128.91
(C3),130.15 (C9),133.11 (C6),136.66 (C5),145.56 (C1a),149.26 (C6a),
150.43 (C2), 152.53 ppm (C8). IR (KBr, n, cm1): ~3078w, 2963w
(n(CareH)), 1617w, 1600m, 1575w, 1498m (n(Car¼ Car) and
n(Car¼N)), 1059vs (nas(BF4)), 832s, 774s (g(CareH)), 793m
(ns(BF4)). UVeVis (DMF/H2O, lmax, nm): 269.0
(ε¼ 5.3.104M1cm1). (þ)ESI-MS (DMF/H2O) m/z (relative in-
tensity): 468.0 [Ag(1,7-phen)2]þ (100), 361.0 [Ag(1,7-phen)
(DMF)]þ (5).
Anal. calcd. for 5¼ C24H16AgF6N4Sb (MW¼ 704.03): C, 40.94; H,
2.29; N, 7.96. Found: C, 40.78; H, 2.15; N, 7.68%. 1H NMR (400MHz,
DMF-d7): d¼ 8.02 (dd, J¼ 8.1, 4.4 Hz, H4), 8.13 (dd, J¼ 8.3, 4.6 Hz,
H10), 8.47 (m, H3 and H9, isochronous), 8.78 (dd, J¼ 8.1, 1.7 Hz, H5),
9.34 (dd, J¼ 4.4, 1.7 Hz, H2), 9.44 (dd, J¼ 4.6, 1.7 Hz, H8), 9.88 ppm
(dd, J¼ 8.3, 1.6 Hz, H6). 13C NMR (101MHz, DMF-d7): d¼ 122.97
(C10), 123.58 (C4), 126.56 (C4a), 127.48 (C10a), 128.85 (C3), 130.60
(C9), 133.73 (C6), 136.72 (C5), 145.42 (C1a), 148.92 (C6a), 150.59
(C2), 153.13 ppm (C8). IR (KBr, n, cm1): ~3082w, 2949w (n(CareH)),
1619w, 1600m, 1575w, 1497m (n(Car¼ Car) and n(Car¼N)), 836s,
778s (g(CareH)), 656vs (n(SbF6)). UVeVis (DMF/H2O, lmax, nm):
269.0 (ε¼ 5.4.104M1cm1). (þ)ESI-MS (DMF/H2O) m/z (relative
intensity): 468.0 [Ag(1,7-phen)2]þ (100), 361.0 [Ag(1,7-phen)
(DMF)]þ (14).
1,7-phen data given for comparative purposes. MW¼ 180.21. 1H
NMR (400MHz, DMF-d7): d¼ 7.98 (m, H4 and H10), 8.33 (dd,
J¼ 53.8, 9.1 Hz, H3 and H9), 8.74 (dd, J¼ 8.1, 1.7 Hz, H5), 9.29 (dd,
J¼ 4.3, 1.6 Hz, H2 and H8), 9.75 ppm (ddd, J¼ 8.3, 1.8, 0.7 Hz, H6).
13C NMR (101MHz, DMF-d7): d¼ 122.51 (C10), 123.17 (C4), 126.47
(C4a), 126.87 (C10a), 129.02 (C3), 129.65 (C9), 132.27 (C6), 136.55
(C5), 145.81 (C1a), 149.74 (C6a), 150.16 (C2), 151.78 ppm (C8). IR
(KBr, n, cm1): 3032w, 2928w (n(CareH)), 1614m, 1584m, 1568m,
1490s, 1426s (n(Car¼ Car) and n(Car¼N)), 846vs, 774vs (g(CareH)).
UVeVis (DMF/H2O, lmax, nm): 267.0 (ε¼ 2.7.104M1cm1).
4.4. Air/light stability
The air/light stability of 1e5 was studied in direct light in air
atmosphere at room temperature in order to mimic their exposure
to light under real life conditions. Sterile cellulose discs were
impregnated with the silver(I) compounds (5 mL of 50mg/mL
DMSO stock solution) and exposed to air and light. The stability was
monitored visually within 48 h.
4.5. Crystallographic data collection and reﬁnement of the
structures
Single crystals of 1, 3 and 4were selected andmounted on a loop
with inert oil on a Stoe IPDS2 diffractometer. The crystals were kept
at 298(2) K (1 and 3) or 250(2) K (4) during data collection. Using
Olex2 [77], the structure was solved with the ShelXT [78] structure
solution program using Intrinsic Phasing and reﬁned with the
ShelXL [79] reﬁnement package using Least Squares minimization.
Hydrogen atom positions were calculated geometrically and
reﬁned using the riding model. Crystal data and details of the
structure determinations are listed in Table S2. MERCURY computer
graphics program [80] was used to prepare drawings.
4.6. Antimicrobial activity
4.6.1. Antibacterial activity
The minimal inhibitory concentrations (MICs) of the silver(I)
complexes 1e5, 1,7-phenanthroline and silver(I) sulfadiazine
(AgSD; Sigma, Munich, Germany) against a panel of ﬁve microor-
ganisms that included Escherichia coli NCTC 9001, Staphylococcus
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aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Klebsiella
pneumoniae ATCC 13883 and Pseudomonas aeruginosa ATCC 27853,
were determined according to the standard broth microdilution
assay, recommended by the American National Committee for
Clinical Laboratory Standards (M07-A8). The tested compounds
were dissolved in DMSO. The highest concentration tested was
500 mg/mL and the inoculums were 105 colony-forming units (cfu/
mL). The MIC value corresponds to the lowest concentration that
inhibited the growth after 24 h at 37 C.
4.6.2. Anti-Candida activity
The minimal inhibitory concentrations (MICs) of the silver(I)
complexes 1e5, 1,7-phenanthroline and AgSD against C. albicans
ATCC 10231, C. parapsilosis ATCC 22019, C. glabrata ATCC 2001 and
C. krusei ATCC 6258 were determined in RPMI 1640 medium
(Gibco) according to Standards of European Committee on Anti-
microbial Susceptibility Testing (v 7.3.1: Method for the determi-
nation of broth dilution minimum inhibitory concentrations of
antifungal agents for yeasts). The tested compounds were dissolved
in DMSO. The highest concentration tested was 500 mg/mL and the
inoculums were 105 cfu/mL. The MIC value corresponds to the
lowest concentration that inhibited the growth after 24 h at 37 C.
4.6.3. Epithelial cells infection model
The ability of C. albicans SC5314 cells to infect epithelial cells
TR146 (obtained from Cancer Research Technology, London) was
tested in the presence of 1 and silver(I) sulfadiazine (AgSD) in the
concentration range of 2e 16 mg/mL (3.77e 30.17 mM for 1 and 5.60
e 44.80 mM for AgSD). C. albicans cells were co-incubated with oral
epithelial cells for 3 h (hyphal length, invasion assay) and 24 h
(damage assay) in serum-free Dulbecco's modiﬁed Eagle's medium
(DMEM; Gibco) at 37 C and 5% CO2 as described in previous pub-
lications [81,82]. In the invasion assay, C. albicans cells were ﬁrst
stained with the Alexa Fluor 488 conjugate of succinylated conca-
navalin A (ConA; Invitrogen). Afterwards, epithelial cells were
permeabilized using 0.5% Triton X-100 and fungal cells stainedwith
calcoﬂuor-white (CFW; Sigma), which allowed differentiation of
invading (stained by CFW only) and non-invading (stained by both
CFW and ConA) hyphae. Using ﬂuorescence microscopy, the per-
centage of invading cells and hyphal length were determined by
counting at least 50 invading Candida cells. Epithelial cell damage
was determined after 24 h by measuring the release of lactate de-
hydrogenase (LDH) using the LDH cytotoxicity detection kit (Roche
Applied Science) according to manufacturer instructions. All ex-
periments were performed in triplicates for each condition and
repeated three times.
4.6.4. Measurement of ROS production in Candida
Intracellular reactive oxygen species (ROS) weremeasured using
the ﬂuorescent dye 20,70-dichloroﬂuorescin diacetate (DCFH-DA,
Sigma) as previously described [83]. Brieﬂy, the C. albicans cells
were adjusted to 107 cells per mL in Sabouraud dextrose broth and
incubated for 1.5 h at 30 C and 200 rpmwith 4xMIC concentrations
of silver(I) complex 1, 1,7-phen and silver(I) sulfadiazine. The pos-
itive control was treated with 4 mg/mL of amphotericin B. After
staining with 10 mM DCFH-DA at 30 C for 30min, the cells were
collected and washed two times with PBS. The ﬂuorescence in-
tensities (excitation and emission of 488 and 540 nm, respectively)
of cells were tested with CyFlow Space Partec ﬂow cytometer with
Partec FloMax software (Partec GmbH, Munster, Germany). This
experiment was carried out three times independently.
4.7. Cytotoxicity
Cytotoxicity in terms of the antiproliferative effect was tested by
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay [84]. The assay was carried out using human lung ﬁ-
broblasts (MRC5) cell line after 48 h of cell incubation in the me-
dium, containing compounds at concentrations ranging from 5 to
200 mM. Brieﬂy, MRC5 cells were maintained in RPMI-1640 me-
dium supplemented with 100 mg/mL streptomycin, 100 U/mL
penicillin and 10% (v/v) fetal bovine serum (FBS) (Gibco) as a
monolayer (1 104 cells per well). All cell lines were grown in
humidiﬁed atmosphere of 95% air and 5% CO2 at 37 C. The MTT
assay was performed two times in four replicates. The extent of
MTT reduction was measured spectrophotometrically at 540 nm
using a Tecan Inﬁnite 200 Pro multiplate reader (Tecan Group Ltd.,
Mannedorf, Switzerland), and the cell survival was expressed as
percentage of the control (untreated cells). Cytotoxicity was
expressed as the concentration of the compound inhibiting cell
growth by 50% (IC50) in comparison to untreated control.
4.8. DNA interaction
4.8.1. Molecular docking
The structures of the tested silver(I) complex 1, [Ag(1,10-
phen)2]þ complex and 1,7-phenanthroline were optimized by
B3LYP method, with 6e31 g** basis set for non-metal atoms and
LanL2DZ basis set for silver. MerzeKollman atomic charges were
calculated at same level, according to the scheme via the restrained
electrostatic potential (RESP) model [85]. Crystal structure of DNA
was extracted from Protein Data Bank (pdb code: 1BNA) [86] and
used for docking study as target for tested compounds. The struc-
ture represents synthetic double stranded dodecamer
d(CpGpCpGpApApTpTpCpGpCpG) with more than one complete
turn of right-handed B helix and without DNA intercalation gap.
The preparation of DNA structure has been carried out using
AutoDock 4.2 software program [87] and includes the adding of
hydrogen atoms and removing water molecules from crystal
structure. In order to generate grid and docking parameter ﬁles in
AutoDockTools program [87], the optimized structures of the tested
compounds and DNA were used. The structure of DNA, [Ag(1,10-
phen)2]þ complex and 1,7-phenanthroline ligand were considered
as rigid, while AgdN coordination bonds of the silver(I) complex 1
were allowed to rotate freely. To accommodate the tested com-
pounds during docking study, a grid box, containing the whole
protein, was used. The virtual screening used Lamarckian genetic
algorithm as the search method and 100 runs for each docking
screen. Discovery Studio (BIOVIA Software product) [88] was used
to analyze and visualize the results of docking studies.
4.8.2. In vitro DNA interaction
For DNA interaction assay high molecular weight (HMW)
genomic DNA isolated from C. albicans ATCC 10231 was used. DNA
was isolated according to method of Nikodinovic et al. [89]. DNA
(100 ng/mL ﬁnal concentration) was incubated with 25 mM ﬁnal
concentration of silver(I) complex 1, 1,7-phen and AgSD in 10mM
Tris-Cl, pH 8.5 in 50 mL reaction volume. After 2 h incubation at
30 C,10 mL aliquotswere taken,mixedwith loading dye and loaded
on agarose gel. Control contained an appropriate volume of DMSO.
DNA samples were run, 500 ng per lane, on 0.8% agarose gel with
ethidium bromide against a O'GeneRuler™ 1 kb Plus DNA Ladder
(band sizes in bp: 75, 200, 350, 400, 500, 700, 1000, 1500, 2000,
3000, 4000, 5000, 7000, 10 000, 20 000) (Thermo Scientiﬁc™) at
50 V for 3 h. Gels were visualized and analyzed using the Gel Doc EZ
system (Bio-Rad, Life Sciences, Hercules, USA), equipped with the
Image Lab™ Software.
4.8.3. CD spectral analysis
CD spectra of double-stranded template DNA (dsDNA) from
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herring sperm (1mg/mL; Boehringer Mannheim GmbH, Germany)
and its complexes with various amounts of 1 (0e500 mM) were
recorded on a Jasco J-815 circular dichroism spectropolarimeter
(JASCO, UK) calibrated with ammonium (þ)-10-camphorsulfonate.
Spectra were recorded over a wavelength range 320e220 nm in
0.1 nm steps at instrument scanning rate of 200 nm/min using a
quartz cell of 0.1 mm optical path length and with data integration
time of 2 s. The obtained values were normalized by subtracting the
baseline recorded for the buffer (10 mM sodium bicarbonate buffer,
pH 8.0). The results are expressed as ellipticity, measured in mdeg.
4.9. Embryotoxicity using the zebraﬁsh (Danio rerio) model
Evaluation of toxicity of 1, 1,7-phen and AgSD on zebraﬁsh
embryos model was carried out according to general rules of the
OECD Guidelines for the Testing of Chemicals [90]. All experiments
involving zebraﬁsh were performed in compliance with the Euro-
pean directive 2010/63/EU and the ethical guidelines of the Guide
for Care and Use of Laboratory Animals of the Institute of Molecular
Genetics and Genetic Engineering, University of Belgrade.
Adult zebraﬁsh (Danio rerio, wild type) were obtained from a
commercial supplier (Pet Center, Belgrade, Serbia), housed in a
temperature- and light-controlled facility with 28 C and standard
14:10-h light-dark photoperiod, and regularly fed with commer-
cially dry ﬂake food (TetraMin™ ﬂakes; Tetra Melle, Germany)
twice a day and Artemia nauplii once daily. Zebraﬁsh embryos were
produced by pair-wise mating, collected and distributed into 24-
well plates containing 10 embryos per well and 1mL embryos
water (0.2 g/L of Instant Ocean® Salt in distilled water), and raised
at 28 C. For assessing lethal and developmental toxicity, embryos
at 6 h post fertilization (hpf) stage were treated with six concen-
trations of complex 1, 1,7-phen and AgSD (1, 2.5, 5, 10, 25 and
50 mM). DMSO (0.2%) was used as a negative control. Experiments
were performed three times using 20 embryos per concentration.
Apical endpoints for the toxicity evaluation (Table S3) were
recorded at 24, 48, 72, 96 and 114 hpf using an invertedmicroscope
(CKX41; Olympus, Tokyo, Japan). Dead embryos were counted and
discarded every 24 h. At 114 hpf, embryos were inspected for
heartbeat rate, anesthetized by addition of 0.1% (w/v) tricaine so-
lution (Sigma-Aldrich, St. Louis, MO), photographed and killed by
freezing at 20 C for 24 h.
4.9.1. Intracellular ROS production in the zebraﬁsh
Generation of intracellular ROS in zebraﬁsh embryos upon 1 and
AgSD treatments was detected using an oxidation-sensitive ﬂuo-
rescent probe dye 20,70-dichloroﬂuorescin diacetate (DCFH-DA).
Brieﬂy, after 48 h treatment with complex 1, respective ligand and
AgSD, the zebraﬁsh embryos were transferred into 96-well plates,
treated with DCFH-DA solution (20 mg/mL) and incubated for 1 h in
the dark at 28.5 C. Following incubation, the zebraﬁsh embryos
were rinsed in the fresh embryo water and anesthetized in 0.1% (w/
v) tricaine solution (Sigma-Aldrich, St. Louis, MO) before imaging.
The images of stained embryos were observed using a ﬂuorescent
microscope (Olympus BX51, Applied Imaging Corp., San Jose, CA,
USA). A ﬂuorescence intensity of individual zebraﬁsh larvae was
measured at an excitation wavelength of 485 nm and an emission
wavelength of 535 nm using a spectroﬂuorometer (Tecan Inﬁnite,
2000 Pro multiplate reader; Tecan Group Ltd., M€annedorf,
Switzerland).
4.9.2. Statistical analysis
The results were expressed as mean values± standard deviation
(SD) and analyzed using Student's t-test at a threshold level of
P¼ 0.5. This analysis was carried out using SPSS 20 (SPSS Inc.,
Chicago, IL) software.
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